Results 191 to 200 of about 2,381,535 (223)

Mechanisms for isoniazid action and resistance.

Novartis Foundation symposium, 1999
Isoniazid is the most widely used antituberculosis drug. Genetic studies in Mycobacterium smegmatis identified the inhA-encoded, NADH-dependent enoyl acyl carrier protein reductase as the primary target for this drug. A reactive form of isoniazid inhibits InhA by reacting with the NAD(H) cofactor bound to the enzyme active site forming a covalent ...
L, Miesel, D A, Rozwarski, J C, Sacchettini, W R, Jacobs   +3 more
openaire   +1 more source

[Resistance to isoniazid].

Revue de la tuberculose, 2003
E, BERNARD, B, KREIS, O, BRUN
openaire   +1 more source

Relation Between In-Vitro and In-Vivo Resistance to Isoniazid.

Lancet, The, 1952
R Knox, J M Robson
exaly  

Identifying Isoniazid Resistance Markers to Guide Inclusion of High-Dose Isoniazid in Tuberculosis Treatment Regimens

Clinical Microbiology and Infection, 2020
Annelies Van Rie, Michael G Whitfield
exaly  

Isoniazid-resistance in tuberculosis

Science, 1998
openaire   +1 more source

MUTATIONAL STUDIES ON THE ISONIAZID RESISTANCE OF A MYCOBACTERIUM

Japanese Journal of Microbiology, 1960
M, TSUKAMURA, K, MIURA, T, ABO
openaire   +2 more sources

Isoniazid/rifampicin resistance

Reactions Weekly, 2017
openaire   +1 more source

[Relation of catalase activity, isoniazid-resistance and pathogenicity of isoniazid-resistance strains].

Annales de l'Institut Pasteur, 2002
B, KREIS, E, LE JOUBIOUX
openaire   +1 more source

Standardized Treatment of Active Tuberculosis in Patients With Previous Treatment And/Or With Mono-Resistance to Isoniazid: A Systematic Review and Meta-Analysis

PLoS Medicine, 2009
Andrea Benedetti, Christian Lienhardt, Dick Menzies   +2 more
exaly  

Streptomycin and isoniazid resistance.

American review of tuberculosis, 2002
R S, MITCHELL, W, STEENKEN
openaire   +1 more source